Loading
Latest filing published 30 Mar 2026 for Sino Biopharmaceutical Ltd., €1.1M.
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Tse Theresa Y Y (chief executive) discloses dealings in Sino Biopharmaceutical Ltd. to HKEX. Over a trading history stretching from 1 March 2018 to 30 March 2026, the count stands at 2 filings.
On the market, this insider has only ever bought: 2 purchases, €1.1M in total. The totals do not cover 1 filing with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2026, the count stands at 1 purchase and no sales.
The newest entry dates from 30 March 2026: an open-market purchase of €1.1M, in Sino Biopharmaceutical Ltd. Source: insider filings from HKEX. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations